Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Company expects up to six-month review period per FDA guidelines New longer-term clinical data demonstrating durable positive brain biochemical and clinical effect for as long as 8.5 years to be...
-
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027 Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be reported by mid-2027 ...
-
Ultimus today announced its role in the successful launch of three new exchange-traded funds (ETFs) for Liberty One Investment Management, LLC.
-
Xos expands Hub lineup with 210, 420, and 630 kWh options starting at $158K, making mobile charging accessible to fleets of all sizes and needs.
-
NOVATO, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
-
Synevra UltraLift ingredients analyzed: 2026 consumer report examines SYN-AKE peptide serum and VitaLock beauty supplement formulation details.
-
WUXI, China, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Mientras la adopción de energía solar fuera de red está en pleno auge en toda América Latina—impulsada por iniciativas gubernamentales de...
-
WUXI, China, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Diante da crescente adoção da energia solar fora da rede em toda a América Latina, impulsionada pelas iniciativas de eletrificação rural lideradas...
-
WUXI, China, Jan. 23, 2026 (GLOBE NEWSWIRE) -- As off-grid solar adoption booms across Latin America—driven by government-led rural electrification initiatives, frequent grid outages that disrupt...
-
Ottawa, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The global sustainable materials market size accounted for USD 421.17 billion in 2026 and is expected be worth nearly USD 1,183.54 billion by 2035,...